Calcitonin gene-related peptide (CGRP) inhibitors are now considered a first-line treatment used to treat and prevent migraines. There are two types of CGRP medications: monoclonal antibodies and ...

The ACP guideline, published in Annals of Internal Medicine, includes three recommendations centered around monotherapy: ...

Decreased tear levels of CGRP and SP correlate with dry eye disease severity and symptoms. Study involved 12 healthy volunteers and 16 DED patients, highlighting significant neuropeptide level ...